ScoreWhy is Shandong Sito Bio-technology Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 1.65%
- The company has been able to generate a Return on Capital Employed (avg) of 1.65% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 2.45% and Operating profit at 12.66% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 1.52% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 2.45% and Operating profit at 12.66% over the last 5 years
4
With a growth in Net Sales of 26.24%, the company declared Very Positive results in Mar 26
- The company has declared positive results for the last 2 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at CNY 199.55 MM
- PRE-TAX PROFIT(Q) Highest at CNY 3.97 MM
- NET PROFIT(Q) Highest at CNY 3.62 MM
5
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -28.95%, its profits have risen by 64.9%
- At the current price, the company has a high dividend yield of 0.2
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Shandong Sito Bio-technology Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Shandong Sito Bio-technology Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Shandong Sito Bio-technology Co., Ltd.
-9.32%
-0.08
32.30%
China Shanghai Composite
3.23%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.45%
EBIT Growth (5y)
12.66%
EBIT to Interest (avg)
0.09
Debt to EBITDA (avg)
7.23
Net Debt to Equity (avg)
0.35
Sales to Capital Employed (avg)
0.39
Tax Ratio
15.52%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.65%
ROE (avg)
1.52%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.19
EV to EBIT
-103.61
EV to EBITDA
47.43
EV to Capital Employed
1.14
EV to Sales
2.53
PEG Ratio
NA
Dividend Yield
0.08%
ROCE (Latest)
-1.10%
ROE (Latest)
-2.73%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend32What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 220.33 MM
NET SALES(HY)
At CNY 612.73 MM has Grown at 20.67%
ROCE(HY)
Highest at 0.55%
PRE-TAX PROFIT(Q)
Highest at CNY 32.47 MM
NET PROFIT(Q)
Highest at CNY 26.61 MM
RAW MATERIAL COST(Y)
Fallen by -143.8% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 1.85 times
OPERATING PROFIT(Q)
Highest at CNY 82.43 MM
OPERATING PROFIT MARGIN(Q)
Highest at 28.95 %
EPS(Q)
Highest at CNY 0.14
-1What is not working for the Company
CASH AND EQV(HY)
Lowest at CNY 497.86 MM
Here's what is working for Shandong Sito Bio-technology Co., Ltd.
Pre-Tax Profit
At CNY 32.47 MM has Grown at 211.66%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Operating Cash Flow
Highest at CNY 220.33 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Pre-Tax Profit
Highest at CNY 32.47 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 26.61 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Net Profit
At CNY 26.61 MM has Grown at 205.69%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Net Sales
At CNY 612.73 MM has Grown at 20.67%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Operating Profit
Highest at CNY 82.43 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Operating Profit Margin
Highest at 28.95 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
EPS
Highest at CNY 0.14
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Inventory Turnover Ratio
Highest at 1.85 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -143.8% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
At CNY 42.36 MM has Grown at inf%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (CNY MM)
Here's what is not working for Shandong Sito Bio-technology Co., Ltd.
Cash and Eqv
Lowest at CNY 497.86 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Footer loading
